CareDx, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving CareDx, Inc. now
Current reporting with the operating signal separated from the noise.
CareDx, Inc. (CDNA) stock price, news, quote and history
Investors are testing whether CareDx, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Which Is a Better Investment, CareDx, Inc. or Recursion Pharmaceuticals, Inc. Stock?
Investors are testing whether CareDx, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.CareDx, Inc (CDNA) Q4 2024 Earnings Call Transcript
Investors are testing whether CareDx, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.CareDx, Inc. (CDNA) Hit a 52 Week High, Can the Run Continue?
The story matters when it changes CareDx, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest CDNA filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
CareDx, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →